您的位置: 首页 > 农业专利 > 详情页

Fusion proteins, pharmaceutical compositions comprising them and their use in the manufacture of medicaments for cancer therapy
专利权人:
ADAMED PHARMA S.A.
发明人:
JERZY SZCZEPAN PIECZYKOLAN,SEBASTIAN DOMINIK PAWLAK,BARTLOMIEJ MACIEJ ZEREK,PIOTR KAMIL ROZGA
申请号:
IL22620513
公开号:
IL226205A
申请日:
2013.05.07
申请国别(地区):
IL
年份:
2018
代理人:
摘要:
A fusion protein comprising domain (a) which is a functional fragment of hTRAIL protein sequence, which fragment begins with an amino acid at a position not lower than hTRAIL95, or a homolog of said functional fragment having at least 70% sequence identity and domain (b) which is a sequence of an anti-angiogenic effector peptide, wherein the sequence of domain (b) is attached at the C-terminus or N-terminus of domain (a). The fusion protein can be used for the treatment of cancer diseases.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充